Ajanta Pharma has entered into an in agreement with Prollenium Medical Technologies, Canada to market its highly successful Dermal Filler 'Revanesse' in India. The company is well established in therapeutic segments like dermatology, cardiology, and ophthalmology with many first to market brands in India. Launch of Revanesse will put the company as a front runner in the aesthetic segment in India and will further boost its corporate equity amongst cosmetologists and dermatologists.
Ajanta Pharma has jumped 6.67% at Rs107 on volumes over 97,000 shares on the BSE.
0 comments:
Post a Comment